Compound May Fight Hard-to-Treat Lung Cancer
December 29th, 2009
Reviewed By Louise Chang, MD
Scientists at the Dana-Farber Cancer Institute say they have developed a compound that may be capable of halting a common type of drug-resistant lung cancer.
Their study is published in the Dec. 24/31 issue of the journal Nature.